{"id":389045,"date":"2024-07-31T00:00:00","date_gmt":"2024-07-31T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/codrta0001-biopharma-regional-forecast-company-drug-global-2024\/"},"modified":"2026-05-07T23:13:03","modified_gmt":"2026-05-07T23:13:03","slug":"codrta0001-biopharma-regional-forecast-company-drug-global-2024","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/codrta0001-biopharma-regional-forecast-company-drug-global-2024\/","title":{"rendered":"Regional Forecast | Company &#038; Drug | Global | 2024"},"content":{"rendered":"<p>Regional Forecast is an add on offering from Clarivate&#8217;s Company &#038; Drugs (C&#038;D) that renders extended coverage of existing C&#038;D proprietary data. With increasing demand to analyze the data in much granularity, market forecasters can now have an in-depth analysis of the data which is now available for different segments (such as therapy area, drug group and drug class) across multiple regions (U.S., Europe, Japan and Others).<\/p>\n<p>Data is readily accessible in the form of downloadable reports \/ interactive dashboard which enables the user to navigate and analyze the data quickly and easily. Data is covered for fourteen\u00a0therapeutic areas mentioned below:<\/p>\n<ul>\n<li>Anti-Infectives<\/li>\n<li>Cardiovasculars<\/li>\n<li>Central Nervous System<\/li>\n<li>Dermatology<\/li>\n<li>Gastrointestinal<\/li>\n<li>Genitourinary<\/li>\n<li>Hematology<\/li>\n<li>Metabolism<\/li>\n<li>Musculoskeletal Pain<\/li>\n<li>Oncology<\/li>\n<li>Ophthalmology<\/li>\n<li>Respiratory<\/li>\n<li>Transplant<\/li>\n<li>Vaccines<br \/>\n\t\u00a0<\/li>\n<\/ul>\n<p><strong>User Guidelines:<\/strong><\/p>\n<p>1.Dashboard has three tabs \u2013 \u2018Regional Data\u2019, \u2018Base Year Analysis\u2019 and \u2018Forecast Analysis\u2019<\/p>\n<p>\u00a0\u00a0\u00a0 a.\u2018Regional Data\u2019 tab details the regional level sales for individual drug classes consolidated at \u00a0<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 drug group and therapy area levels<\/p>\n<p>\u00a0\u00a0\u00a0 b.\u2018Base Year Analysis\u2019 tab enables the user to quickly analyze and compare sales at drug<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 class and drug group levels<\/p>\n<p>\u00a0\u00a0\u00a0 c.\u2018Forecast Analysis\u2019 tab enables the user to assess the forecast \u2002\u2002\u2002\u2002<\/p>\n","protected":false},"template":"","class_list":["post-389045","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/389045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/389045\/revisions"}],"predecessor-version":[{"id":575930,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/389045\/revisions\/575930"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=389045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}